18.03.21
Cannabis Law Report
In the quest to become GMP compliant, design and flow of your manufacturing facility are critical. Mistakes in the design phase will cost money and eventual time loss, so taking this step seriously and planning to the end for every detail must be a top priority.
26.02.21
Benzinga Capital Conference
Michael Sassano, CEO of Somai Pharmaceuticals talk about the European Cannabis Market and how it is starting to look like the USA 10 years ago
25.02.21
Cannabis Business Executive
Despite Europe’s unification, each country is still making their own rules on providing access to medical cannabis for patients. Currently there are 14 countries in Europe that recognize cannabis products for medical sales.
24.02.21
Ticker Tape
Early February marked a big step for the cannabis industry with the announcement that Jazz Pharmaceuticals (JAZZ) will pay $7.2 billion for cannabis-based epilepsy drug maker GW Pharmaceuticals (GWPH).
09.02.21
Cannabis Law Report
The path to facility and product approval in cannabis is a long road that requires attention to detail and proper knowledgeable people to guide the project from start to finish and beyond.
03.02.21
B2B Wholesaler Magazine
Mike Sassano, CEO and Chairman of Somai Pharmaceutical: “2021 is shaping up to be the most explosive country-by-country cannabis legalization movement yet. The political and individual wills have gained a hefty majority, which will mark 2021 as the year everywhere gets these initiatives passed and by the end of the year there will only be some really awful and strict countries with no human rights that are against legal medical cannabis.”
01.02.21
IdeaMensch
There is way more to cannabis than getting “high.” The United States alone has grossed a total between $71.4B-$87.5B in 2020 contributing to cannabis’s total economic impact (according to Marijuana Business Daily).
06.01.21
CBDevious
The legality of cannabis for medical and recreational use varies by country, in terms of its possession, distribution, and cultivation, and how it can be consumed and what medical conditions it can be used for.
28.12.20
Cannabis Business Executive
Since my first job on Wall Street at Lehman Brothers, I was taught to raise money. And now, with a landmark vote by the EU to reclassify cannabis as medicine, the race to raise cannabis money is on.
Europe has watched cannabis reform unfold in the US and Canada for some time; European countries have accordingly followed North American trends for every industry group. Business creativity knows no borders and raising capital has no limits.
Here are 9 considerations for raising capital for European startups: